• CFTRinh-172 Workflow for CFTR Inhibition

  2026-09-17

  CFTRinh-172 gives researchers rapid, reversible control of CFTR chloride conductance without directly targeting cAMP production or membrane trafficking. This article connects acute transport assays with surface-abundance measurements, epithelial disease models, and troubleshooting strategies for more interpretable cystic fibrosis research.

• PPP1R3G/PP1γ Control of RIPK1 Cell Death

  2026-09-16

  The reference study identifies PPP1R3G as a regulatory subunit that recruits PP1γ to TNFR1 complex I, removes inhibitory RIPK1 phosphorylation, and enables RIPK1-dependent apoptosis and type I necroptosis. Its genetic, biochemical, and in vivo evidence establishes phosphatase-controlled RIPK1 activation as a key connection between inflammatory signaling and regulated cell death.

• MRSA EVs Drive OSCC Proliferation via IL-8

  2026-09-16

  This study shows that extracellular vesicles released by methicillin-resistant Staphylococcus aureus can enter oral squamous cell carcinoma cells and stimulate tumor growth more strongly than vesicles from methicillin-susceptible S. aureus. Its mechanistic contribution is the identification of an EV–ERK/c-Jun–IL-8–CXCR1 signaling axis, supported by IL-8 knockout and CXCR1-blockade experiments in an ectopic tumor model.

• Ivermectin, GSDMC, and Translational Rigor

  2026-09-15

  A translational perspective on Ivermectin as a broad-spectrum anti-parasitic and on GSDMC biology in pancreatic cancer, separating established parasitology utility from hypothesis-generating oncology research.

• CCR7–Notch1 Crosstalk Promotes Mammary Cancer Stemness

  2026-09-15

  Boyle et al. identify a functional interaction between CCR7 and Notch1 in primary MMTV-PyMT mammary tumor cells, linking chemokine signaling to cancer stem-like behavior. Their genetic and pathway-blockade experiments suggest that simultaneous disruption of both axes may be more informative than studying either pathway in isolation, although translation beyond this mouse model remains unresolved.

• Pretomanid Targets Both Terminal Oxidases in Tuberculosis

  2026-09-14

  The reference study identifies the cytochrome bcc:aa3 and cytochrome bd terminal oxidases as coordinated respiratory targets of pretomanid in Mycobacterium tuberculosis. Its combination data show that pairing pretomanid with Q203, with or without ND-011992, can strengthen killing across replicating and antibiotic-tolerant states while limiting resistance emergence.

• Salvianolic acid B in Pulmonary Fibrosis Research

  2026-09-14

  Salvianolic acid B, also called Dan Shen Suan B, gives fibrosis researchers a practical way to connect LH2 expression with collagen cross-linking, matrix stiffness, and tissue remodeling. This guide translates the published mechanism into concentration-response, cell-based, and orthogonal ECM workflows while addressing solubility, assay interference, and interpretation limits.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-09-13

  This guide explains how to handle Angiotensin I/II (1-5), a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research. It is suited to cardiovascular, renal, blood pressure, and aldosterone workflows, but its poor water solubility and fragment-specific scope limit use in unrelated assays.

• DAPI (hydrochloride): Assay Workflows & Troubleshooting

  2026-09-12

  DAPI (hydrochloride) provides a practical DNA readout for fixed-cell imaging, flow cytometry, chromosome staining, and selected live-cell assays. This guide connects its minor-groove binding chemistry with reproducible workflows, immune-cell applications, organoid analysis, and troubleshooting decisions.

• Cardiogreen (Indocyanine Green): Uses & Limits

  2026-09-11

  Cardiogreen, also called Indocyanine green, is a near-infrared tricarbocyanine dye that remains primarily within the vascular space after intravenous administration. Its documented uses include cardiac output measurement, liver blood flow assessment, ophthalmic angiography, and experimental apoptosis induction in photodynamic therapy.

• 5-(N,N-dimethyl)-Amiloride: Assay Design

  2026-09-11

  5-(N,N-dimethyl)-Amiloride hydrochloride is a precise tool for dissecting sodium–proton exchange, intracellular pH regulation, and endothelial injury. This guide develops a causal assay framework that connects ion-transport perturbation with moesin, barrier, and cardiac readouts without overstating the available evidence.

• Influenza Hemagglutinin (HA) Peptide for Reliable IP

  2026-09-10

  Learn how Influenza Hemagglutinin (HA) Peptide, SKU A6004, supports controlled HA-tagged protein detection, immunoprecipitation, and elution when cell viability or cytotoxicity data require mechanistic follow-up. This scenario-based guide connects product specifications with practical assay design, interpretation, and vendor-selection decisions.

• 2',7'-Dichlorofluorescein diacetate in Pancreatic Cancer

  2026-09-10

  A translational guide to using 2',7'-Dichlorofluorescein diacetate for intracellular ROS measurement, interpreting redox-responsive nanocarrier studies, and connecting fluorescence signals with tumor penetration, extracellular matrix remodeling, mitochondrial function, and therapeutic decision-making.

• Nicotinamide Riboside Chloride in RGC Translation

  2026-09-09

  Nicotinamide Riboside Chloride (NIAGEN) offers a mechanistically grounded way to examine NAD+ availability alongside reproducible iPSC-derived retinal ganglion cell models. This thought-leadership perspective connects NAD+ biology with dual SMAD and Wnt-controlled differentiation, while separating established evidence from testable translational hypotheses in glaucoma and neurodegenerative disease research.

• ARCA and the Translational Logic of mRNA Therapy

  2026-09-09

  Synthetic mRNA performance is shaped by more than delivery: cap orientation influences translation initiation, RNA persistence, and the amount of therapeutic protein produced per particle. This thought-leadership analysis connects ARCA chemistry with the preclinical stroke study by Gao et al., showing how translational researchers can evaluate capping as a strategic variable without overstating evidence.

8638 records 1/576 page Next 12345 下5页 Last page